DK3368519T3 - Hidtil ukendte, heterocykliske antiøstrogener - Google Patents

Hidtil ukendte, heterocykliske antiøstrogener Download PDF

Info

Publication number
DK3368519T3
DK3368519T3 DK16859220.2T DK16859220T DK3368519T3 DK 3368519 T3 DK3368519 T3 DK 3368519T3 DK 16859220 T DK16859220 T DK 16859220T DK 3368519 T3 DK3368519 T3 DK 3368519T3
Authority
DK
Denmark
Prior art keywords
antiostrogenes
heterocyclic
hitherto unknown
hitherto
unknown
Prior art date
Application number
DK16859220.2T
Other languages
English (en)
Inventor
Ranjan Kumar Pal
Amit Pravinbhai Sedani
Kaushikkumar Dhanjibhai Prajapati
Dijixa Pinakin Rana
Sandeep Pankajbhai Pathak
Japan Nitinkumar Desai
Jayraj Dilipbhai Aradhye
Bhavesh Mohanbhai Panchal
Indraneel Ghosh
Trinadha Rao Chitturi
Original Assignee
Sun Pharma Advanced Res Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharma Advanced Res Co Ltd filed Critical Sun Pharma Advanced Res Co Ltd
Application granted granted Critical
Publication of DK3368519T3 publication Critical patent/DK3368519T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
DK16859220.2T 2015-10-27 2016-10-26 Hidtil ukendte, heterocykliske antiøstrogener DK3368519T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN4058MU2015 2015-10-27
PCT/IN2016/050364 WO2017072792A1 (en) 2015-10-27 2016-10-26 Novel heterocyclic antiestrogens

Publications (1)

Publication Number Publication Date
DK3368519T3 true DK3368519T3 (da) 2022-05-23

Family

ID=58629986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16859220.2T DK3368519T3 (da) 2015-10-27 2016-10-26 Hidtil ukendte, heterocykliske antiøstrogener

Country Status (26)

Country Link
US (2) US10865199B2 (da)
EP (2) EP4043438A1 (da)
JP (2) JP6855475B2 (da)
KR (1) KR20180088375A (da)
CN (1) CN108699021B (da)
AU (1) AU2016347679B2 (da)
BR (1) BR112018008375B1 (da)
CA (1) CA3001958A1 (da)
DK (1) DK3368519T3 (da)
EA (1) EA034131B1 (da)
ES (1) ES2916223T3 (da)
HR (1) HRP20220640T1 (da)
HU (1) HUE059386T2 (da)
IL (2) IL283559B (da)
LT (1) LT3368519T (da)
MX (1) MX2018005305A (da)
PH (1) PH12018500829A1 (da)
PL (1) PL3368519T3 (da)
PT (1) PT3368519T (da)
RS (1) RS63217B1 (da)
SA (1) SA518391423B1 (da)
SG (2) SG11201803119XA (da)
SI (1) SI3368519T1 (da)
UA (1) UA122348C2 (da)
WO (1) WO2017072792A1 (da)
ZA (1) ZA201802615B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA122348C2 (uk) * 2015-10-27 2020-10-26 Сан Фарма Адвансед Ресьорч Компані Лімітед Нові гетероциклічні антиестрогени
MX2018007079A (es) 2015-12-09 2018-11-12 The Board Of Trustees Of Univ Of Illinois Reguladores a la baja del receptor de estrogeno selectivo de benzotiofeno.
WO2018081168A2 (en) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective mixed estrogen receptor downregulators
MX2019008158A (es) 2017-01-06 2019-12-09 G1 Therapeutics Inc Terapia de combinacion para el tratamiento del cancer.
US10208011B2 (en) 2017-02-10 2019-02-19 G1 Therapeutics, Inc. Benzothiophene estrogen receptor modulators
JP2022541938A (ja) * 2019-07-22 2022-09-28 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド 選択的エストロゲン受容体分解剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
DE69023906T2 (de) 1990-08-09 1996-04-11 Council Scient Ind Res Benzopyrane und Verfahren zu deren Herstellung.
US6060503A (en) 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
US5407947A (en) 1993-11-05 1995-04-18 Eli Lilly And Company Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans
US5389646A (en) 1993-12-30 1995-02-14 Zymogenetics, Inc. Methods for treatment and prevention of bone loss using 2,3-benzopyrans
US5916916A (en) * 1996-10-10 1999-06-29 Eli Lilly And Company 1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods
WO1999002512A1 (en) 1997-07-09 1999-01-21 Novo Nordisk A/S Dl-2,3-diaryl-2h-1-benzopyrans
DE10013782A1 (de) * 2000-03-15 2001-10-18 Schering Ag 4-Fluoralkyl-2H-benzopyrane mit antiestrogener Wirksamkeit, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
WO2004091488A2 (en) * 2003-04-14 2004-10-28 Merck & Co., Inc. Estrogen receptor modulators
EP1846397A1 (en) * 2005-01-21 2007-10-24 Janssen Pharmaceutica N.V. Novel heterocyclic benzoy[c]chromene derivatives useful as modulators of the estrogen receptors
US20100317635A1 (en) * 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
CN102939287B (zh) * 2010-06-10 2016-01-27 塞拉根制药公司 ***受体调节剂及其用途
US9193714B2 (en) 2011-12-14 2015-11-24 Seragon Pharmaceuticals, Inc. Fluorinated estrogen receptor modulators and uses thereof
MD20140054A2 (ro) 2011-12-16 2014-10-31 Olema Pharmaceuticals, Inc. Compuşi noi de benzopiran, compoziţii şi utilizări ale acestora
WO2014203132A1 (en) * 2013-06-19 2014-12-24 Olema Pharmaceuticals, Inc. Substituted benzopyran compounds, compositions and uses thereof
WO2014205138A1 (en) 2013-06-19 2014-12-24 Seragon Pharmaceuticals, Inc. Estrogen receptor modulator and uses thereof
BR112015030595A2 (pt) 2013-06-19 2017-07-25 Seragon Pharmaceuticals Inc moduladores de receptor de estrogênio de azetidina e usos dos mesmos
US20160175284A1 (en) 2014-12-18 2016-06-23 Genentech, Inc. Estrogen receptor modulators and uses thereof
JP6768711B2 (ja) 2015-05-26 2020-10-14 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 複素環式エストロゲン受容体モジュレーター及びその使用
UA122348C2 (uk) * 2015-10-27 2020-10-26 Сан Фарма Адвансед Ресьорч Компані Лімітед Нові гетероциклічні антиестрогени

Also Published As

Publication number Publication date
SA518391423B1 (ar) 2021-03-31
EA034131B1 (ru) 2020-01-09
EP3368519B1 (en) 2022-04-06
BR112018008375A2 (pt) 2018-10-23
ZA201802615B (en) 2022-10-26
ES2916223T3 (es) 2022-06-29
LT3368519T (lt) 2022-06-10
IL258949B (en) 2021-06-30
PL3368519T3 (pl) 2022-06-06
PT3368519T (pt) 2022-05-25
JP2021098749A (ja) 2021-07-01
EP4043438A1 (en) 2022-08-17
US10865199B2 (en) 2020-12-15
CA3001958A1 (en) 2017-05-04
JP6855475B2 (ja) 2021-04-07
SG10201913001SA (en) 2020-03-30
PH12018500829A1 (en) 2018-10-15
IL283559B (en) 2022-07-01
US20210053947A1 (en) 2021-02-25
SI3368519T1 (sl) 2022-07-29
CN108699021B (zh) 2022-10-04
HUE059386T2 (hu) 2022-11-28
EA201890981A1 (ru) 2018-09-28
IL283559A (en) 2021-07-29
AU2016347679B2 (en) 2020-06-25
JP2018536647A (ja) 2018-12-13
JP7052111B2 (ja) 2022-04-11
EP3368519A1 (en) 2018-09-05
US11465990B2 (en) 2022-10-11
UA122348C2 (uk) 2020-10-26
KR20180088375A (ko) 2018-08-03
IL258949A (en) 2018-06-28
US20180354936A1 (en) 2018-12-13
MX2018005305A (es) 2019-04-29
BR112018008375B1 (pt) 2023-12-12
WO2017072792A1 (en) 2017-05-04
SG11201803119XA (en) 2018-05-30
HRP20220640T1 (hr) 2022-07-08
RS63217B1 (sr) 2022-06-30
EP3368519A4 (en) 2019-04-10
CN108699021A (zh) 2018-10-23
AU2016347679A1 (en) 2018-05-10

Similar Documents

Publication Publication Date Title
DOP2018000256A (es) 3-oxo-2,6-difenil-2,3-dihidropiridazin-4-carboxamidas
DK3405050T3 (da) Børnesikret snusbeholder
DK3319956T3 (da) Substituerede oxopyridinderivater
DK3253762T3 (da) 9h-pyrrolo-dipyridinderivater.
DK3436823T3 (da) Antigen-array
DK3445708T3 (da) Stigbøjle
DK3335532T3 (da) Tandharve
DK3402792T3 (da) Quinolin-2-on-derivater
DK3509963T3 (da) Pallecontainer
DK3368519T3 (da) Hidtil ukendte, heterocykliske antiøstrogener
DK3528829T3 (da) Bacitracin-alginat-oligomer-konjugater
ES1150114Y (es) Abarcón.
DK3575238T3 (da) Pallecontainer
ES2968023T3 (es) Derivados de oxoisoquinolina novedosos
DK3097076T3 (da) Hidtil ukendte cyp-eicosanoidderivater
DE112017006386A5 (de) Schraubarbeitszylinder
DE112017000734A5 (de) Glycolsensor
IT201600102119A1 (it) Seminatrice
DK3471535T3 (da) Dyrelift
DK3277813T3 (da) Hidtil ukendt terapi
DK3323708T3 (da) Bovfender
DK3452590T3 (da) Plademagnet
DK3452587T3 (da) Penicillin-g-acylaser
DK3436447T3 (da) Isoquinolinyl-triazolon-komplekser
DK3295800T3 (da) Sandwichkiksindretning